GLP-1 agonists (also known as GLP-1 receptor agonists or analogs) are a class of synthetic medications designed to mimic the actions of the natural GLP-1 hormone
This conventional method, for some long peptides and peptide fragments with strong hydrophobicity, is easy to form beta-sheet secondary structure through intramolecular hydrogen bond during synthesis, thereby causing shrinkage of resin and resulting in coupling difficulty
Few commercial payers cover GLP-1s for weight loss alone (e.g., some Blue Cross Blue Shield plans cover Wegovy), and only for certain plans/tiers and if stringent criteria are met (e.g., body mass index (BMI) above a certain threshold)
doi:10.1007/s11910-013-0394-8 Moharregh-Khiabani D, Linker RA, Gold R, Stangel M (2009) Fumaric Acid and its esters: an emerging treatment for multiple sclerosis
GLP-1, which stands for Glucagon-like peptide-1, is a hormone produced by special cells in the intestines